REDUX ON THE ROPES

BAD NEWS, BAD LUCK AND TOO HIGH HOPES ADD UP TO DISAPPOINTING SALES FOR LAST YEAR'S HOT NEW DIET PILL

The distinctive black-and-white sweater-striped pill was supposed to make millions of Americans thin--and its manufacturer rich. But a year after the drug called Redux was approved by the Food and Drug Administration for sale in the U.S., the hot new diet pill has fallen short on both counts. At $200 million a year, sales are flat and lagging far behind the initial $1 billion-a-year expectations. Some who have taken Redux have discovered that it is not the magic melting potion they hoped it would be; others who were thinking of taking it have been frightened off by stories about potentially harmful...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!